🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Mičigen › Ann Arbor

Kliničke studije za Akutna mijeloidna leukemija u gradu Ann Arbor, MI

17 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Ann Arbor i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Тражи се учесникФаза 1
  • University of Michigan Rogel Cancer Center, Ann Arbor
Узраст 21 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07737769

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Тражи се учесникФаза 3
  • University of Michigan, Ann Arbor
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • и још 1
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 ми удаљено
Узраст 60 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07437950

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • и још 4
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 3
  • Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 ми удаљено
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 ми удаљено
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • C S Mott Children's Hospital, Ann Arbor
До 21 година · Оба пола · Ажурирано 23. 10. 2026. · NCT07012044

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • C S Mott Children's Hospital, Ann Arbor
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Тражи се учесникФаза 3
  • C S Mott Children's Hospital, Ann Arbor
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 9. 2026. · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • C S Mott Children's Hospital, Ann Arbor
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • University of Michigan, Ann Arbor
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • University of Michigan, Ann Arbor
Узраст 18 и старији · Оба пола · Ажурирано 15. 6. 2026. · NCT05768932

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Тражи се учесникФаза 1
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Ann Arbor

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.